Whalesbook
Albert David Limited's Board of Directors met on May 12, 2026, to approve its audited financial results for the fiscal year ending March 31, 2026. The board also recommended a final dividend of ₹5.00 per equity share and appointed Mr. Amit Mahla as the new Chief Executive Officer (CEO), effective the same date. The company reported a net profit of ₹17.20 crore on revenue from operations of ₹333.60 crore.
The financial statements received an unmodified audit opinion from M/s. L. B. Jha & Co., reinforcing the credibility of the reported performance. M/s. PricewaterhouseCoopers Services LLP and M/s. S. Gupta & Co. were re-appointed as Internal Auditors and Cost Auditors, respectively, for the fiscal year 2026-27.
The appointment of Amit Mahla, a seasoned professional with over 28 years of pharmaceutical market experience, suggests Albert David may pursue a new strategic direction. The dividend recommendation provides a direct return to shareholders, reflecting confidence in the company's financial position.
The 87th Annual General Meeting (AGM) is scheduled for August 6, 2026, with July 30, 2026, set as the record date for dividend entitlement and AGM participation.
Albert David Limited, an Indian pharmaceutical company founded in 1935, manufactures and markets pharmaceutical formulations and bulk drugs. Public records show no major corporate actions or strategic shifts for the company in the past two years.
The company operates within the highly competitive Indian pharmaceutical sector. Key competitors include larger entities like Cipla Ltd, Sun Pharmaceutical Industries Ltd, and Dr. Reddy's Laboratories, which possess extensive global reach and diverse product lines. Smaller players such as Indoco Remedies and FDC Limited also compete across various therapeutic segments, while Albert David appears focused on specific market niches within India.
No specific risks related to this announcement were detailed in the filing.
Investors will be closely watching the shareholder vote on the proposed final dividend at the AGM. Key developments to track include the strategic initiatives and vision outlined by the new CEO, Mr. Amit Mahla, and future performance updates under his leadership. Any specific disclosures or resolutions during the 87th AGM will also be important.